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Abstract 
The mechanism regulating the formation of insoluble immune complexes (IIC) in serum in certain disease states is not well 
understood. Ovalbumin and rabbit anti-ovalbumin IgG was used to study the formation of IIC in vitro in a stirred reaction vessel; and the 
radii of IIC that formed was determined by light scattering techniques. Using an initial IgG concentration of 1 mg/ml at equivalence 
antigen:antibody ratio IIC formation was detected within 5 s, and the complexes increased in radii to approx. 100 nm after 20-30 s (phase 
1). This was followed by a phase (phase 2) in which the complexes rapidly increased in radii to the point where Mie scattering was 
reached (~ 200 nm). The time of onset of the second phase decreased with increasing initial IgG concentrations at a fixed 
antigen:antibody ratio; and was at a minimum at equivalence antigen:antibody ratio, but increased at both antigen and antibody excess 
ratios. Immune complexes formed using F(ab') 2 fragment showed a similar pattern to those formed using IgG. A similar pattern was seen 
in the presence of the complement component Clq which potentiated IIC formation in phase 2, and human serum (1:10 dilution) which 
attenuated IIC formation in both phases. For complex formation using IgG and ovalbumin the presence of NaC1 at concentrations up to 
0.6 M led to a progressive increase in the time of onset of phase 2; potencies of inhibition by other sodium halides followed the lyotropic 
series NaF < NaCI < NaI. The results suggest that formation of IIC occurs in at least two distinct phases, and that the second phase 
leading to the generation of very large insoluble complexes i associated with a rapid polymerisation f the complexes by a mechanism 
that is not dependent on Fc:Fc interactions. 
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I. Introduction 
Although the formation of insoluble immune complexes 
between antibodies and their cognate antigens has been 
implicated in the pathogenesis of a number of diseases 
including rheumatoid arthritis, hitherto the mechanisms 
that regulate immune complex formation are poorly under- 
stood. It is known that insoluble immune complexes form 
when polyclonal antibody (Ab) preparations are incubated 
with their cognate antigens (Ag), and this system has been 
widely used as a model to study immune complex forma- 
tion in vitro [1]. Evidence suggests that two classes of 
interactions may be important in immune complex forma- 
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tion: the interactions between epitopes on the antigen and 
the antigen binding sites of the antibody molecules [2], and 
the less well-defined interactions between the Fc regions 
of antibody molecules [1,3-8]. Moreover, it has been 
proposed that formation of insoluble immune complexes 
occurs in three distinct steps, as shown below. These 
include: the rapid formation of soluble antibody:antigen 
complexes within the first few seconds of the reaction 
(Step 1), followed by the subsequent polymerisation of 
these soluble complexes to form larger insoluble species in 
a process lasting several minutes (Step 2) and the coales- 
cence of the larger species to form precipitates on a time 
scale of minutes to hours (Step 3) [9]. 
xAb + yAg ~ AbxAgy Step 1 
nAbxAgy ~ (AbxAgy)= Step2 
(Ab x Ag y),  ~ precipitate Step 3 
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The experimental techniques that have been used to 
study immune complex formation in vitro, include sedi- 
mentation methods [4], electron microscopy [2] and light 
scattering techniques [2,9-11]. Since the formation of 
insoluble immune complexes leads to the generation of a 
turbid suspension, and the turbidity or light scattering and 
absorbing properties of the suspension is related to the size 
of the particles in the suspension [ 12] we recently carried 
out estimates of the size of insoluble immune complexes 
that formed as a function of time by measuring the light 
scattering properties of the suspension at different wave- 
lengths [13]. In those studies [13] only a single mixing of 
the reactants was carded out at the start of the reaction. 
The procedure, therefore, assumes that the size of the 
particles is small enough such that their rate of sedimenta- 
tion does not significantly affect the measurement of light 
scattering and absorbance. The procedure is likely to lead 
to inaccuracies, however, for larger particle sizes when the 
sedimentation rate is greater. This effect also is reflected 
by studies noting differences in the formation of IgG:anti- 
IgG immune complexes upon stirring the solution when 
determining particle size using light scattering techniques 
[14]. 
In the present work we have employed a continuous 
mechanical stirring of the reaction solution and measure- 
ment of light scattering to determine the rate of increase in 
the size of immune complexes formed between ovalbumin 
and anti-ovalbumin antibodies. Our results show that the 
rate of increase of insoluble immune complex size occurs 
in two phases and that both phases, are dependent on the 
antigen and antibody concentrations, and ionic strength. 
The data presented is consistent with the scheme outlined 
above, and suggest hat an additional critical step in the 
formation of insoluble immune complexes occurs when the 
particles reach approx. 100 nm in radius. 
2. Materials and methods 
2.1. Materials 
Rabbit anti-ovalbumin IgG and its F(ab') 2 fragment 
were prepared as previously described [1]. Human Clq 
was purified from human serum as previously described 
[15]. Human serum was obtained from the supernatant 
after incubation of fresh human blood at 37°C for 30 min 
and centrifugation for 15 min at 1000 X g. The coupling of 
anti-ovalbumin IgG to CNBr-activated Sepharose 4B 
(Pharmacia-LKB), and of ovalbumin (Sigma) to glu- 
taraldehyde-activated glass (Boehringer-Mannheim), both 
were carried out according to the manufacturer's instruc- 
tions. 
2.2. Insoluble immune complex formation and absorbance 
measurement 
Immune complex formation was carded out at 37°C in a 
quartz reaction cuvette in buffer containing 0.15 M NaC1, 
3 mM NaN 3 and 0.01 M sodium phosphate (pH 7.4, PBS), 
or in 0.01 M sodium phosphate (pH 7.4) and 3 mM NaN 3 
also containing either anti-ovalbumin IgG or its F(ab') 2 
fragment, as indicated. For some experiments NaCI at 
concentrations up to 1 M also was included as detailed in 
the text. For experiments carried out in the presence of 
human serum, both the anti-ovalbumin IgG and the serum 
were mixed in 5 mM sodium barbitone (pH 7.4) containing 
125 mM NaCI, 0.5 mM MgC12 and 0.15 mM CaCI 2 
(BBS2+). The final reaction volume for immune complex 
formation in the cuvette was 2 ml; and the solution was 
stirred continuously with the aid of a magnetic stirrer. The 
formation of insoluble immune complexes was initiated by 
the addition of the appropriate amount of ovalbumin. 
Following initiation of immune complex formation the 
absorbance was monitored every 5 s using a Hewlett- 
Packard 8452A diode array spectrophotometer with the 
quartz reaction cuvette and cell-holder maintained at 37°C. 
The acquisition time was 0.2 s and absorbance measure- 
ment was carried out at a range of wavelengths between 
350 and 510 nm. Theoretical considerations (Dr. M. An- 
drews, personal communication) and empirical measure- 
ments (data not shown) indicated that under the conditions 
used stirring did not significantly alter the relationship 
between the absorbance of the solution and the size of the 
insoluble immune complexes in the suspension (see below). 
2.3. Affinity chromatography 
Samples of ovalbumin or anti-ovalbumin IgG (both in 
PBS) were applied to columns of, anti-ovalbumin IgG 
conjugated to Sepharose 4B or ovalbumin coupled to 
glutaraldehyde-glass, re pectively, equilibrated in the same 
buffer. Unbound material was eluted from the columns 
with PBS. The columns were eluted with a linear gradient 
from 0.15 to 1 M NaC1, followed by 0.1 M glycine HC1 
(pH 2.8) containing 3 mM NaN 3. 
2.4. Precipitin analysis 
For precipitin analysis the insoluble immune complexes 
that formed in each solution were collected by centrifuging 
(104 X g, 1 min), and washing three times in PBS before 
dissolving in 0.2 M NaOH. The extent of immune complex 
formation was then calculated by measuring the ab- 
sorbances of each solution at 280 nm, assuming E 0.1% 
(w/v)  = 1.4 for IgG. 
2.5. Theory and data analysis 
At each time point the size of insoluble immune com- 
plexes that formed was determined from the absorbance 
measurements at different wavelengths of light by the 
method described previously [13]. This method uses the 
equation 
32McTr3no2( 6n/~c)2/ (2 .303 X 3N) 
Abs = /~4 + AD2no2A 2 (1) 
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This equation is based on the theory developed by 
Cashin and Debye [16] and Stacey [12] relating the wave- 
length (A) dependence of the absorbance (Abs) of a turbid 
suspension in terms of the molecular weight (M) of the 
light-scattering species, its weight concentration (c), the 
refractive index of the medium (no), the change in refrac- 
tive index with the concentration of the light-scattering 
species (~n/~c) ,  Avogadro's number (N), the diameter 
(D) of the light-scattering species, and a shape constant 
(A) being 6.056 for spherical particles. The size of insolu- 
ble immune complexes was determined by fitting Eq. (1) 
to the measured value of the absorbance of the suspension 
at each time point by non-linear egression analysis [17]; 
the radii of immune complexes being calculated from the 
fitted values of the denominator term in Eq. (1). It should 
be noted that Eq. (1) applies to a Rayleigh-Debye scatterer, 
with dimensions comparable to, but less than A. Immune 
complexes with radii greater than one-half of the wave- 
length of the incident light, (greater than A/2 × no) give 
rise to Mie scattering, which is not described by this 
equation [18]. For radii less than this, however, the equa- 
tion has been shown to accurately relate the absorbance to 
particle size as determined by EM studies [2] and also by 
the use of polystyrene microspheres of known radii [13]. 
The Rayleigh equation assumes that all particles in the 
suspension are of the same size. The formation of insolu- 
ble immune complexes involves a polymerisation process 
which can lead to the formation of particles of different 
sizes with low standard eviation. Therefore, in each set of 
experiments it was important to establish the wavelengths 
for which the absorbance gave the best estimate of the 
average particle size while taking into account he limita- 
tion of measurable size (radius less than, A/2 X n o) in the 
Rayleigh-Debye range. This was done by checking that a 
straight line was obtained when plotting 1 / (Abs  X A 2) vs. 
A 2, since Eq. (1) can be simplified to: 
Abs = a/ (  A 4 + bA 2) 
where 
a = 32Mcrr3no2( 6n /6c)2 / (2 .303 × 3N) 
b =AD2no 2 
which can be linearized to give Eq. (2) 
1/ (Abs X A 2) = h 2 X ( l /a )  + (b /a )  (2) 
For each time point of insoluble immune complex 
formation only the measured values of absorbances that 
gave a straight line when plotting A 2 vs. 1/ (Abs X A 2) 
was used to estimate the a and b numbers by fitting Eq. (1) 
to the absorbances using non-linear egression analysis. 
The maximum measurable radius was in the range of 
140-200 nm for absorbance measurements at wavelengths 
350-510 nm. Absorbance readings generally were in the 
range of 0.001 to 0 .80D units and were dependent on 
initial concentration of reactants. The radius of immune 
complexes was calculated using the value of b in the 
denominator term (radius = ((b/An2o)°5)/2). 
3. Results 
3.1. The formation of insoluble immune complexes in a 
stirred solution 
Previous studies on the formation of insoluble immune 
complexes in a non-agitated solution of IgG and ovalbu- 
min indicated that the increase in particle size reaches a 
plateau after about 10 min [13]. In the present study the 
formation of insoluble immune complexes in a solution of 
ovalbumin:anti-ovalbumin IgG was studied in a stirred 
cuvette to avoid inaccuracies due to sedimentation f the 
complexes that formed; the size of the particles being 
determined by measuring the absorbance of the solution 
due to light scattering by the insoluble particles. Compared 
to the no-mix conditions the initial rate of the reaction was 
increased approx. 10-fold when the reaction vessel was 
continuously stirred by a magnetic stirrer (data not shown). 
The absorbance at different wavelengths in the range of 
350 to 510 nm as a function of time after initiation of the 
immune complex formation is shown in Fig. 1A. The radii 
of the immune complexes that formed at each time point 
during the progress curve shown in Fig. 1A was deter- 
mined by applying Eq. (1) to the absorbance data. As 
shown in Fig. 1B, the increase in immune complex size 
can be divided into two phases. In the first phase, the radii 
of the immune complexes increase with time, but approach 
a limit of approx. 100 nm by the first 150 s of initiation of 
immune complex formation. In the second phase, which 
begins at about 150 s the immune complexes increase 
rapidly in size until their diameter becomes greater than 
the wavelength of the incident light (at about 230 s in the 
present studies), and at which point Eq. (1) becomes 
invalid. 
Since the rapid increase in the radii of immune com- 
plexes was not seen in our previous study in which the 
reaction solution was not stirred, it was important o 
establish the validity of Eq. (1) in the Rayleigh-Debye 
range for the present system. Consistent with the observa- 
tion of Tanford [18] and Stacey [12], the data in Fig. 2A 
show that the Rayleigh theory is not applicable when the 
diameter of immune complexes are much smaller than the 
wavelength of the light (less than A/20 X no), since a 
straight line is not seen on plotting 1 / (Abs  X A 2) vs. A2 
at the early time points (5, 15 and 20 s). However, when 
the diameter of immune complexes are in Rayleigh-Debye 
range, using data corresponding to the first and second 
phase of the progress curve, an approx, linear relationship 
is obtained by plotting 1 / (Abs  × A z) vs. A 2 as shown in 
Fig. 2B and C, respectively. Subsequently, when the diam- 
eter of immune complexes became larger than the wave- 
length of the light the breakdown of Eq. (1) was apparent 
from the fact that the plots of 1 / (Abs  × A 2) vs. A 2 for 
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Fig. 1. The wavelength dependence of light scattering byIgG-Ovalbumin 
containing immune complexes. The formation ofinsoluble immune com- 
plexes was initiated by adding ovalbumin to give 0.0075 mg/ml to a 
solution of anti-ovalbumin IgG (0.25 mg/ml) in PBS. Each point in (A) 
represents the absorbance associated with light scattering by the immune 
complexes atthe indicated time measured atthe wavelength of:350 nm 
(E), 390 nm (n), 430 nm (O), 470 nm (O) and 510 nm (A). Each 
point in (B) represents the mean radius of immune complexes formed at 
the indicated times, determined from radii for each wavelength calculated 
by fitting Eq. (1) onto the data shown in (A) as outlined in Section 2. The 
SEM for the radius at each time point shown in (B) was determined from 
the result of the separate computation forthe five different wavelengths 
shown in (A). 
the time points tested became less linear (see Fig. 2D). 
After careful consideration of the region in which Eq. (1) 
is valid for each series of data a and b numbers were 
calculated by fitting Eq. (1) to the measured absorbances 
by non-linear egression analysis. The a and b values 
were checked by linear regression analysis which showed 
that a straight line was obtained for each individual wave- 
length b plotted against a /Abs ,  and that the slope and 
intercept of each straight line was very close to A 2 and 
A 4, respectively (data not shown). The reason the ab- 
sorbances shown in Fig. 1A do not show the sharp increase 
reflected in the size data in Fig. 1B is that 1 /Abs  is 
correlated with D 2. 
The rapid polymerisation of insoluble immune com- 
plexes that occurred during the second phase of immune 
complex formation lead to the generation of very large 
particles that could readily be seen by visual inspection, as 
shown in the series of photographs in Fig. 3. Interestingly, 
when the initial IgG concentration was 3 mg/ml at equiva- 
lence antigen:antibody ratio, 30 min after initiation of the 
reaction the majority of the immune complexes could be 
seen floating on the top of the cuvette (data not shown), 
suggesting that under these conditions immune complexes 
polymerise rapidly and escape from turbulence. 
3.2. The effects of lgG concentration and the antigen:anti- 
body ratio on the size of immune complexes 
In order to determine whether the biphasic change in 
the size of the immune complexes was a general feature of 
immune complex formation in this system, immune com- 
plex formation was studied at different input concentration 
of IgG. As shown in Fig. 4A, these experiments indicated 
that for each input IgG concentration the radii of the 
immune complexes formed increased to a limit of approx. 
100 nm initially, and then was followed by a rapid increase 
in size which continued until approx. 50 s and 230 s, for 
concentrations of 1 mg/ml and 0.25 mg/ml, respectively. 
The results also show that the biphasic change in the rate 
of increase in the size of immune complexes is indepen- 
dent of the initial IgG concentration. However, the time of 
onset of the rapid increase in radii was dependent on the 
input IgG concentration, ranging from approx. 30 s for 1 
mg/ml  IgG, to approx. 150 s for 0.25 mg/ml IgG (Fig. 
4A). 
The formation of insoluble immune complexes from the 
F(ab') 2 fragment of anti-ovalbumin IgG and ovalbumin 
also showed a biphasic change in the rate of increase in 
particle size which was independent of the concentration 
of the F(ab') 2. The data in Fig. 4B show that, over a range 
of input concentrations of F(ab') 2, during the first 20 and 
78 min of initiation of immune complex formation the 
radii of these immune complexes increased to dimensions 
(approx. 100 nm radius) similar to that seen for complexes 
containing IgG (Fig. 4A). At each concentration f F(ab')2 
tested this increase was followed by a rapid increase in the 
size of the F(ab') 2 containing immune complexes (Fig. 
4B) which continued until the radii reached approx. 200 
nm. Similar to the formation of IgG immune complexes 
(Fig. 4A), the time of onset of the rapid increase in the 
sizes of the F(ab') 2 containing immune complexes varied 
inversely with the input F(ab') 2 concentration (Fig. 4B). It 
was approx. 20 and 90 min, when the initial concentration 
of F(ab') 2 was 2.25 mg/ml and 0.56 mg/ml, respectively. 
Although a decrease in the size of IgG:anti-IgG immune 
complexes formed with increasing concentrations of the 
antigen after a 3 h incubation was noted previously [14], 
the effect of antigen concentration  the size of insoluble 
immune complexes has not been studied in detail. Previous 
studies have provided evidence that at a fixed concentra- 
tion of IgG increasing concentrations of antigen lead to an 
increased in the lag phase in the formation of immune 
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complexes (see, e.g., Easterbrook-Smith et al., [1]). We 
examined, therefore, the effects of varying the antigen 
concentration on the size of the insoluble immune com- 
plexes that formed as a function of time. As shown in Fig. 
4C, changes in the antigen concentration does not alter the 
basic shape of the response to that observed previously for 
IgG (Fig. 4A) and for F(ab') 2 fragment (Fig. 4B). Thus, 
there was an initial increase in radii up to approx. 100 nm 
during the first 60-70 s, followed by a more rapid increase 
in the immune complex size. Interestingly, however, the 
time of onset of the rapid increase in immune complex size 
was dependent on the initial antigen concentration. The 
time of onset of the rapid increase in size of immune 
complexes was at a minimum (approx. 65 s) for the 
equivalence antigen:antibody ratio of 0.03:1 (w/w),  but 
increased at both antigen excess (approx. 270 s for an 
antigen:antibody ratio of 0.06:1) and at antibody excess 
(approx. 160 s for an antigen:antibody ratio of 0.015:1) 
(see Fig. 4C). 
3.3. The effect of Clq and serum on immune complex 
formation 
Since the formation of insoluble immune complexes is 
reported to be modulated by serum proteins [1,19-21], the 
effect of human C 1 q and human serum on IIC formation 
was also examined using the stirred reaction system. Ex- 
periments were carried out in which anti-ovalbumin IgG 
was pre-incubated for 5 min in the absence or presence of 
400/zg /ml  human Clq, before initiating IIC formation by 
the addition of ovalbumin at the equivalence Ag:Ab ratio. 
As previously, the size of IIC that formed as a function of 
time was determined by applying Eq. (1) to the absorbance 
data. As shown in Fig. 5A, the presence of Clq (400 
/~g/ml) significantly potentiated the increase in IIC size 
beginning at times approximately coincident with the onset 
of the second phase of the progress curve (i.e. approx. 150 
s after initiating the reaction). The effect of Clq became 
more significant towards the end of the curve (i.e. at 
approx. 210 s) where the average radius of IIC formed in 
the presence of C lq was approx. 40% greater than the 
control (see Fig. 5A). Other experiments indicated that the 
effect of Clq was dose-dependent i  the range of 100-400 
/~g/ml, with the effect still being detectable at 100/~g/ml  
C lq (not shown). The results suggest hat C lq potentiates 
the rate of IIC, and that the potentiation occurs predomi- 
nantly during the second phase of the response. 
Similar experiments carried out in the presence of hu- 
man serum instead of Clq to examine the effect of serum 
proteins on IIC formation, indicated that serum attenuated 
the increase in the size of IIC with time. As shown in Fig. 
5B, the presence of serum (at 1:10 dilution) resulted in a 
slight lowering of the progress curve; the general shape of 
the curve, however, was similar to that seen in the absence 
of serum. Higher concentrations of serum were not used in 
these studies as these induced large fluctuations in the 
absorbance readings (data not shown). 
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Fig. 2. Linear regression analysis of the light scattering data used to determine the size of insoluble immune complexes. The measured values of 
absorbances at various wavelength associated with light scattering by 0.25 mg/ml IgG and ovalbumin atequivalence antigen:antibody ratio was used to 
estimate the size of immune complexes by linear egression analysis by plotting A 2 vs. 1/(Abs × A2). The results in each panel correspond to the data 
obtained at the times indicated inseconds as follows: A. 5 (•), 15 ([]), 20 (O), 30 (O) and 40 (• )  s. B. 60 (•), 80 ([]), 100 (O), 120 (O), 140 (•)  s. 
C. 160 (•), 180 (D), 200 (Q), 220 (O) s. D 240 (ll), 250 (•), 260 (O), 270 (O), 280 (•), 290 (z~) s. 
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3.4. The effect of ionic strength on insoluble immune 
complex formation 
To assess the importance of  ionic interactions on the 
two phases of  increase in immune complex size, we exam- 
ined the effect of  increasing the ionic strength of the 
reaction solution. For these experiments the absorbance 
data is shown in Fig. 6A, and the corresponding immune 
complex size data determined by applying Eq. (1) to this 
data is shown in Fig. 6B. It can be seen that increasing 
concentrations of  NaC1 from 0.15 M to 0.6 M lead to a 
progressive decrease in the rate at which immune com- 
plexes formed from IgG and ovalbumin. At 600 mM NaC1 
immune complexes increased in size up to radii of  approx. 
100 nm during the first 90 s, and then was fo l lowed by a 
more rapid increase in particle size. Although the increase 
in the size of  the complexes hows a pattern similar to that 
seen at 150 mM NaC1, the presence of  higher NaC1 
concentration increased the onset t ime at which the rapid 
increase occurred (compare Fig. 6B and Fig. 4A, B and C). 
Aff inity chromatography of the IgG using ovalbumin glass 
showed that no signif icant amounts of  IgG were eluted 
Fig. 3. Rapid polymerisation of immune complexes. Insoluble immune 
complexes that were formed at 0,10, 60 and 600 s after the initiation of 
the reaction by mixing 1 mg/ml IgG and ovalbumin at equivalence 
antigen:antibody ratio in a stirred reaction vessel are shown in pho- 
tographs A, B, C and D, respectively. 
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Fig. 4. The effect of antibody concentration on the size of immune 
complexes formed from ovalbumin and IgG or F(ab') 2. The formation of 
insoluble immune complexes was initiated by adding ovalbumin to give 
an antigen:antibody ratio of 0.03:1 (w/w) to solutions of anti-ovalbumin 
IgG at 1.0 (A), 0.75 (©), 0.5 (O), 0.375 (1:2) and 0.25 (• )  mg/ml in 
PBS. The radii of the immune complexes formed as a function of time (at 
the wavelengths indicated in the legend to Fig. 1) was determined as 
detailed in Section 2 and is shown in (A). B. The formation of insoluble 
immune complexes using F(ab') 2 fragment of IgG instead of IgG. The 
formation of insoluble immune complexes was initiated by adding oval- 
bumin to give an antigen:antibody ratio of 0.03:1 (w/w) to a solutions of 
F(ab') 2 (made from of anti-ovalbumin IgG) at 0.56 (•) ,  1.15 (D), 1.71 
(Q) and 2.25 (©) mg/ml in PBS as in Section 2. C. The effect of 
antigen:antibody ratio on the size of insoluble immune complexes that 
formed. The formation of insoluble immune complexes was initiated by 
adding ovalbumin to give antigen:antibody ratios (w/w) of 0.015:1 (•) ,  
0.03:1 (n), 0.045:1 (0)  and 0.06:1 (©) to solutions of anti-ovalbumin 
IgG (0.5 mg/ml) in PBS. In each instance the absorbances associated 
with light scattering by the immune complexes at the wavelengths given 
in Fig. 1 were measured, and the sizes of the immune complexes 
calculated from the results of fitting Eq. (1) onto the data as described in 
the legend to Fig. 1. 
from the column at NaC1 concentrations up to 1 M. 
Similarly, NaCI at concentrations up to 1 M was found not 
to elute ovalbumin bound to columns of anti-ovalbumin 
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Fig. 5. The effect of human Clq and serum on the formation of insoluble 
immune complexes. The formation of insoluble immune complexes was 
initiated by adding ovalbumin to give a concentration of 0.0075 mg/ml  
to a solution of anti-ovalbumin IgG (0.25 mg/ml)  in 0.01 M sodium 
phosphate (pH 7.4) containing 3 mM NaN 3 and 400 /zg/ml of human 
Clq. The absorbance associated with light scattering by immune com- 
plexes that formed as a function of time was measured at the wavelengths 
given in Fig. 1. For each time point the radii of immune complexes that 
formed in the absence (indicated • ), and in the presence of 400 /xg/ml 
Clq (indicated D), were determined by fitting the Eq. (1) onto the 
absorbance data (not shown) and are shown in (A). Similarly, (B) shows 
the radii of immune complexes that formed following the addition of 
ovalbumin (0.011 mg/ml )  to a solution of anti-ovalbumin IgG (0.375 
mg/ml )  in BBS 2+ in either the absence (indicated • )  or in the presence 
of human serum (1:10 dilution, indicated 1:3). These radii also were 
calculated by fitting the Eq. (1) to the absorbance data (not shown); for 
other details, see legend to Fig. 1. 
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Fig. 6. The effect of NaCI concentration on the initial rate of formation 
and size of immune complexes. The formation of insoluble immune 
complexes was initiated by the addition of ovalbumin (0.03 mg/ml  final 
concentration) to a solution of anti-ovalbumin IgG (1 mg/ml)  in 0.01 M 
sodium phosphate (pH 7.4) containing 3 mM NaN 3 and NaC1 at concen- 
trations of 150 (• ) ,  200 (n ) ,  300 (Q), 400 (©), 500 (A), or 600 (zx) 
mM. The absorbances associated with light scattering by the immune 
complexes at the wavelengths given in Fig. 1 were measured and is 
shown in (A); for clarity only the absorbances at350 nm are shown. The 
radii of immune complexes which formed in the presence of 150 ( I ) ,  
200 (D), 300 (0) ,  400 (O), 500 (A),  or 600 (A)  mM NaC1 were 
calculated from the results of fitting Eq. (1) onto the data shown in (A) 
and is shown in (B). 
Table 1 
The effect of NaC1 on immune precipitation 
[NaC1] (M) A280 
0.15 0.76+0.01 
0.20 0.76 + 0.01 
0.30 0.75 +0.01 
0.40 0.71 +0.04 
0.50 0.73 4- 0.03 
0.60 0.72 4- 0.05 
IgG conjugated to Sepharose 4B (data not shown), suggest- 
ing that the observed effect of NaC1 was not mediated by 
disrupting the ability of the antigen binding sites of the 
IgG to recognise epitopes on ovalbumin. Consistent with 
these findings, precipitin analyses showed that the extent 
of formation of insoluble immune complexes was not 
affected by NaCI at concentrations up to 0.6 M (Table 1). 
As shown in Fig. 7 additional studies showed that the 
inhibition of immune complex formation by other sodium 
The formation of insoluble immune complexes was initiated by adding 
ovalbumin to give 0.03 mg/ml  final concentration to samples of anti- 
ovalbumin IgG (1 mg/ml)  in 0.01 M sodium phosphate (pH 7.4) plus 3 
mM NaN 3 and containing the indicated concentrations of NaC1, and 
incubating at 37°C. After an incubation period of 18 h immune complexes 
were collected by centrifuging (104;,< g, 1 min); they were then washed 
three times with 0.01 M sodium phosphate buffer containing the indicated 
concentrations of NaCI (as above) and dissolved in 0.2 M NaOH. The 
absorbance of the solution was measured at 280 nm; each absorbance 
value shown is the mean of triplicate samples obtained from one experi- 
ment 
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Fig. 7. The effect of Na halides on the initial rate of formation of 
insoluble immune complexes. The formation of insoluble immune com- 
plexes was initiated by adding ovalbumin to give 0.03 mg/ml  to a 
solution of anti-ovalbumin IgG (1 mg/ml )  in 0.01 M sodium phosphate, 
pH 7.4 plus 3 mM NaN 3 and containing NaF ( zx ), NaCI ( • ) or NaI ( [] ) 
each at a concentration of 150 mM. The absorbance at 350 nm associated 
with light scattering by the immune complexes at each time point was 
measured as in Section 2. 
halides followed the lyotropic series, with relative poten- 
cies of inhibition being NaF < NaC1 < NaI. 
4. Discussion 
The data presented suggest that the formation of insolu- 
ble immune complexes in a continuously stirred solution 
occurs in at least two phases by a mechanism dependent 
on the concentration of the antibody, the antibody:antigen 
ratio and the ionic strength of the reaction medium. In this 
system, initiation of immune complex formation by mixing 
the antibody and antigen led to the generation of insoluble 
immune complexes of radii up to approx. 100 nm, and was 
followed by a rapid increase in the size of the immune 
complexes until they reached the Mie scattering region. 
Although the present estimates of the radii of the immune 
complexes during the early stages (< 30 s) are comparable 
to those obtained previously [13], the rapid increase in the 
size of the complexes after reaching the critical size of 
approx. 100 nm was not observed in those studies; this is 
most likely due to sedimentation as the solution was not 
stirred during the incubation. In the present study employ- 
ing continuous mechanical stirring of the solution, a rapid 
polymerisation and formation of very large insoluble im- 
mune complexes in the second phase of the progress curve 
could readily be observed by inspection (Fig. 3), further 
supporting the data obtained by absorbance measurements. 
The observation that the time of onset of the rapid increase 
in the size of immune complexes i inversely related to the 
input IgG concentration (Fig. 4A) also is consistent with 
mass-action considerations and the dependence on the 
mean distance separating immune complexes in a solution. 
Interestingly, a similar pattern of immune complex for- 
mation was observed using F(ab') 2 fragment of IgG in- 
stead of IgG (compare Fig. 4A and B). This suggests that 
the phase of rapid increase in the size of the immune 
complexes, including the increase that occurs after the 
critical radius is reached, is not dominated by substantial 
interactions between the Fc portions of antibody molecules. 
This conclusion also is supported by the similarity between 
the IgG and F(ab') 2 data patterns as a function of protein 
concentration (see Fig. 4). These observations suggest that 
an interaction between the Fab region of antibody 
molecules is important for the rapid polymerisation pro- 
cess that is seen in the second phase of the response. The 
onset time of the rapid increase was delayed approx. 
70-fold when F(ab') 2 fragment of IgG was used instead of 
whole IgG (compare Fig. 4A and B). This suggests an 
involvement of the Fc region of IgG molecule in the 
formation of small complexes with radius less than 100 
nm, and is consistent with previous tudies [1,3-8]. 
A number of serum proteins have been proposed to 
modulate the formation of insoluble immune complexes 
under physiological conditions. These include an immuno- 
globulin-binding protein gp60 which blocks the effects of 
complement proteins on the formation of immune com- 
plexes [22], and the complement protein Clq which en- 
hances the formation of IIC. It is reported that Clq en- 
hances the formation of insoluble immune complexes in 
vitro by interacting with the CT2 domain of IgG and 
cross-linking IgG molecules [ 1,19,23]. Consistent with pre- 
vious studies our results show that the presence of Clq 
leads to a concentration-dependent potentiation of the rate 
of increase in the size of IIC formed between ovalbumin 
and anti-ovalbumin IgG (Fig. 5A). Interestingly, this 
potentiation was seen predominantly during the second 
phase of the progress curve when already formed insoluble 
complexes undergo rapid polymerization; there was no 
significant potentiation during the first phase (insolubilisa- 
tion phase). This observation suggests that a stronger 
Clq-IgG interaction occurs when IgG is cross-linked with 
its cognate antigens and is insoluble, and is consistent with 
the findings that the affinity of the binding of Clq to 
aggregated IgG is higher than for binding to soluble IgG 
[24], and that an ionic-hydrophobic two-step process is 
involved in the contact between Clq and IgG [25]. 
Activation of classical complement pathway by nascent 
immune complexes i reported to inhibit IIC formation by 
the generation of complement component C3b and its 
covalent binding to the Fc (CT2 or hinge domains) and/or 
Fab portion of IgG molecule, with subsequent disruption 
of the antigen:antibody and/or Fc:Fc interactions involved 
in precipitation of immune complexes [19-21,26]. Al- 
though it was not possible to carry out experiments using 
undiluted human serum due to the high protein concentra- 
tions causing difficulties in measuring absorbances, our 
studies using human serum (1:10 dilution) indicate that 
serum can attenuate the formation of IIC, but that like the 
response seen in the presence of Clq, the general biphasic 
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shape of the response is not changed (Fig. 5B). This 
suggests that the two phases of IIC formation between 
ovalbumin and anti-ovalbumin IgG observed using a stirred 
reaction system also occur under conditions which more 
closely mimic the in vivo system, and hence that they may 
have physiological relevance. 
Another finding from the present work is that the 
time-dependent i crease in the size of IIC during the first 
phase of the response when the average radius is < 100 
nm is affected by ionic strength (0.6 M NaC1, Fig. 6). This 
finding provides evidence that ionic interactions play a 
role in IIC formation. Consistent with previous studies 
[14], our results also indicate that the extent of IIC forma- 
tion is not affected by NaCI at concentrations up to 0.6 M 
(Table 1). It is unlikely that the inhibitory effect of NaC! 
on the first phase of the progress curve (Fig. 6A and B) is 
due to the inhibition of the binding of ovalbumin to the 
IgG, since 0.6 M NaC1 did not affect the binding of 
anti-ovalbumin IgG to ovalbumin. As expected, inhibition 
of complex formation by other sodium halides followed 
the lyotropic series, with relative potencies of inhibition 
being NaF < NaC1 < NaI (Fig. 7). Interestingly, analogous 
to a previous report on the effects of sodium halides on the 
binding of complement component Clq to immune com- 
plexes [23], we found that sodium halides also decreased 
the time of onset of the second phase of increase in size of 
complexes made from ovalbumin and F(ab') 2 fragment of 
anti-ovalbumin IgG (data not shown). These findings sug- 
gest that ionic interactions between the Fab or hinge 
regions of different antibody molecules occur during the 
first phase of the response. 
Crystallographic studies have shown that hydrophobic 
interactions may dominate the contact between an antigen 
and the antigen binding sites of antibody molecules [2]. 
Ionic interactions probably involving polar histidine 
residues within Fc region of the antibody molecule, how- 
ever, may be important in 'Fc:Fc interactions' involved in 
the formation of IIC [8]. Such ionic interactions between 
hydrophilic regions of antibody molecules may permit a 
rapid interaction and formation of homogenous oluble 
immune complexes (as shown in the Steps 1-3 in Section 
1). In addition to hydrophobic antigen binding sites, the Fc 
and Fab fragments of an IgG molecule also consist of 
hydrophobic patches [27-29]. It is likely therefore, that the 
phase of rapid polymerisation (phase 2) observed in this 
study involves the random polymerisation of hydrophobic 
complexes (shown schematically as Steps 2 and 3 in 
Section 1), allowing complexes to reach their maximum 
size dependent on the initial concentration f antibody and 
antigen. This phase is unlikely to be dominated by the 
interaction between the antigen and antigen binding sites 
on the antibody, since insoluble complexes reaching mm in 
size could be observed by inspection. This notion also is 
consistent with the similarities in the progress curve of 
immune complex formation between ovalbumin and anti- 
ovalbumin IgG, and ovalbumin and anti-ovalbumin F(ab') 2 
fragment which suggest that Fc:Fc interactions do not play 
a major role in the phase of rapid increase in immune 
complex size (Fig. 4A and B). 
It has been suggested that the size of IIC is an important 
parameter in inducing pathological changes [19]. Effective 
mechanisms for eliminating IIC from the circulation are 
necessary to limit immune complex-mediated tissue injury 
[30]; such protective measures include mechanisms which 
inhibit IIC formation, as well as those which promote 
solubilisation of already formed IIC. The present study 
shows that the formation of IIC between ovalbumin and 
anti-ovalbumin IgG in a stirred reaction system does not 
occur as a single step reaction, but occurs in two distinct 
phases that may be differently affected by factors that 
modulate IIC formation. Clearly, the use of a stirred 
reaction system as employed in this work should prove 
useful in elucidating the mechanisms that regulate IIC 
formation. In future studies it will be essential to estab- 
lished whether the effect of any soluble factor or serum 
protein(s) on the formation of IIC arises primarily from a 
pertubation of the first phase (formation of complexes with 
radii up to 100 nm), or of the second phase during which 
insoluble complexes undergo rapid polymerization. 
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